Artistic Dental Of Polk City, Llc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 120 Carter Blvd, Suite 7, Polk City, FL 33868 Phone: 863-984-0000 |
Kreative Dental Care Pa Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 120 Carter Blvd Ste 7, Polk City, FL 33868 Phone: 863-984-0000 |
News Archive
Tiny molecules called microRNAs, only 19 to 21 nucleotides in length, are able to effectively silence sometimes large sets of genes. They do this by specifically binding to and neutralizing another form of RNA called messenger RNA, responsible for conveying the information from genes to the cellular machinery that uses that information to create proteins, the building blocks of the body.
Diamyd Medical AB, to date no drug related Serious Adverse Events have been reported by any patient included in Diamyd's Phase I clinical trial investigating NP2 as a potential therapy for chronic pain. Based upon the Phase I findings to date, the company is planning a multi-center, randomized, double-blind, placebo controlled Phase II clinical trial with NP2 in the United States.
Facebook just rolled out an interactive map showing how many people have reported symptoms of coronavirus disease (COVID-19) in counties across the United States. The map helps to determine the extent of the coronavirus pandemic in the country, providing insight into the areas needing more resources and which parts can be reopened.
Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando.
Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable doctors to target more aggressive treatment to children at risk of more severe arthritis, while those likely to have milder disease could be spared the stronger treatments that carry a greater risk of side effects. The researchers were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health.
› Verified 4 days ago